Surgery Partners Inc (NASDAQ:SGRY)’s share price dropped 6.5% during mid-day trading on Thursday . The stock traded as low as $8.44 and last traded at $8.55. Approximately 532,281 shares were traded during trading, an increase of 105% from the average daily volume of 259,813 shares. The stock had previously closed at $9.14.
SGRY has been the topic of several recent research reports. Stifel Nicolaus set a $12.00 price target on Surgery Partners and gave the stock a “hold” rating in a research report on Wednesday, May 8th. BidaskClub upgraded Surgery Partners from a “hold” rating to a “buy” rating in a research report on Thursday, February 7th. ValuEngine lowered Surgery Partners from a “buy” rating to a “hold” rating in a research report on Thursday, February 7th. Finally, Zacks Investment Research upgraded Surgery Partners from a “strong sell” rating to a “hold” rating in a research report on Wednesday, April 24th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $17.60.
The company has a quick ratio of 1.37, a current ratio of 1.49 and a debt-to-equity ratio of 2.20. The stock has a market capitalization of $475.50 million, a PE ratio of -3.49 and a beta of 2.47.
In other Surgery Partners news, Director Adam T. Feinstein sold 7,865 shares of the stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $9.95, for a total value of $78,256.75. Following the completion of the sale, the director now owns 8,895 shares in the company, valued at approximately $88,505.25. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 8.20% of the company’s stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Citigroup Inc. lifted its holdings in Surgery Partners by 40.5% in the 1st quarter. Citigroup Inc. now owns 3,512 shares of the company’s stock worth $40,000 after buying an additional 1,013 shares during the period. Quantamental Technologies LLC purchased a new stake in Surgery Partners in the 1st quarter worth approximately $50,000. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in Surgery Partners in the 4th quarter worth approximately $54,000. Metropolitan Life Insurance Co. NY lifted its holdings in Surgery Partners by 351.4% in the 4th quarter. Metropolitan Life Insurance Co. NY now owns 6,766 shares of the company’s stock worth $66,000 after buying an additional 5,267 shares during the period. Finally, Menta Capital LLC purchased a new position in shares of Surgery Partners in the 4th quarter valued at approximately $99,000. Institutional investors and hedge funds own 96.76% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by Rockland Register and is the sole property of of Rockland Register. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://rocklandregister.com/2019/05/30/surgery-partners-sgry-trading-down-6-5.html.
About Surgery Partners (NASDAQ:SGRY)
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
Featured Article: What is a Stop Order?
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.